OncoMatch

OncoMatch/Clinical Trials/NCT06492460

2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma

Is NCT06492460 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies Drug:Cisplatin for squamous cell carcinoma of head and neck.

Phase 3RecruitingSun Yat-sen UniversityNCT06492460Data as of Jun 2026Location: China

Treatment: Drug:CisplatinThe main objective of this trial was to determine the value of 2 courses of cisplatin concurrent chemotherapy in postoperative adjuvant radiotherapy for high-risk head and neck squamous cell carcinoma.

Check if I qualify

Extracted eligibility criteria

Treatments studied

Chemotherapy

Drug:Cisplatin

Cancer type

Head and Neck Squamous Cell Carcinoma

Disease stage

Required: Stage III, IV

Demographics

Ages ≤ 70

Prior therapy

Must have received: surgery — radical

Radical surgery has been performed with high risk factors (one of below)

Cannot have received: chemotherapy

Exception: induction chemotherapy prior to surgery

Previous chemotherapy (except induction chemotherapy prior to surgery)

Cannot have received: radiation therapy

Previous radiation therapy

Lab requirements

Blood counts

WBC > 4×10^9/L; hemoglobin > 120g/L in males, 110g/L in females; platelet count > 100×10^9/L

Kidney function

creatinine clearance > 60 ml/min

Liver function

ALT, AST < 1.5x ULN; ALP < 2.5x ULN; bilirubin < ULN

Normal bone marrow function: white blood cell count > 4×10^9/L, hemoglobin > 120g/L in males, 110g/L in females, platelet count > 100×10^9/L. Normal liver function: ALT, AST < 1.5x ULN; ALP < 2.5x ULN; bilirubin < ULN. Normal renal function: creatinine clearance > 60 ml/min.

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT06492460 currently recruiting?

Yes, this trial is currently recruiting patients.

Are there prior therapy exclusions?

Yes. Prior chemotherapy, radiation therapy disqualifies patients from enrollment.

What disease stage is eligible?

Stage III or IV is required.

Is there an age limit?

Yes. Patients must be 70 years or younger.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify